Regeneron Announces Investor Conference Presentations

Rhea-AI Summary

Regeneron Pharmaceuticals (NASDAQ: REGN) has announced its participation in four major healthcare investor conferences in May and June 2025:

• BofA Securities 2025 Health Care Conference on May 13 at 1:00 p.m. ET
• RBC Capital Markets Global Healthcare Conference on May 20 at 11:00 a.m. ET
• Bernstein 41st Annual Strategic Decisions Conference on May 28 at 11:00 a.m. ET
• Goldman Sachs 46th Annual Global Healthcare Conference on June 9 at 10:40 a.m. ET

All sessions will be accessible through webcasts on Regeneron's investor relations website, with replays and transcripts available for at least 30 days after the events.

TARRYTOWN, N.Y., April 21, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:

• BofA Securities 2025 Health Care Conference at 10:00 a.m. PT (1:00 p.m. ET) on Tuesday, May 13, 2025
• 2025 RBC Capital Markets Global Healthcare Conference at 11:00 a.m. ET on Tuesday, May 20, 2025
• Bernstein 41^st Annual Strategic Decisions Conference at 11:00 a.m. ET on Wednesday, May 28, 2025
• Goldman Sachs 46^th Annual Global Healthcare Conference at 10:40 a.m. ET on Monday, June 9, 2025

The sessions may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays and transcripts of the webcasts will be archived on the Company's website for at least 30 days.

About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases.

Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite^®, which produces optimized fully human antibodies and new classes of bispecific antibodies. We are shaping the next frontier of medicine with data-powered insights from the Regeneron Genetics Center^® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.

For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.

Contact Information:
Investor Relations
Ryan Crowe
914.847.8790
ryan.crowe@regeneron.com

FAQ

What investor conferences will Regeneron (REGN) attend in May-June 2025?

Regeneron will participate in four conferences: BofA Securities (May 13), RBC Capital Markets (May 20), Bernstein Strategic Decisions (May 28), and Goldman Sachs Global Healthcare (June 9).

How can investors access Regeneron's (REGN) conference presentations in 2025?

Investors can access the webcasts through Regeneron's website at investor.regeneron.com/events-and-presentations. Replays and transcripts will be available for 30 days.

What time is Regeneron's (REGN) presentation at the 2025 Goldman Sachs Healthcare Conference?

Regeneron will present at the Goldman Sachs Global Healthcare Conference on June 9, 2025, at 10:40 a.m. ET.

When is Regeneron (REGN) presenting at the 2025 BofA Securities Healthcare Conference?

Regeneron will present at the BofA Securities Healthcare Conference on May 13, 2025, at 1:00 p.m. ET (10:00 a.m. PT).